Patients with Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement

In the context of the current global COVID-19 pandemic, this Consensus Statement provides current recommendations for patients with, or at risk of developing, genetic heart disease, and for their health care management and service provision in Australia and New Zealand. Apart from general recommendations, there are specific recommendations for the following conditions: cardiomyopathy, Brugada syndrome (including in children), long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT).

Source: Heart, Lung and Circulation - May 6, 2020 Category: Cardiology Authors: Belinda Gray, Christopher Semsarian, Diane Fatkin, Jodie Ingles, John J. Atherton, Andrew M. Davis, Prashanthan Sanders, Nicholas Pachter, Jonathan R. Skinner, Martin K. Stiles, CSANZ Cardiovascular Genetic Diseases Council Tags: Consensus Statement Source Type: research